• About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
Menu
  • About
    • Our Team
    • Our Partners
    • Our Work
  • Tools
    • Case Definitions
    • Vaccine Safety Templates
    • Translations
    • Benefit-Risk Assessment Module
  • Resources
    • News
    • Newsletter
    • Safety by Numbers
    • Webinars
  • Training
    • DSMB Training
    • CDC Training​
    • Vaccine Courses
  • SPEAC
MPOX
JOIN
Posted on February 9, 2022August 3, 2023

ACIP Meeting Report – Feb 4th 2022

Following the FDA approval of Moderna COVID-19 vaccine (Spikevax) for individuals 18 years and older on 31JAN2022, ACIP met today...
Read More
Posted on January 11, 2022August 3, 2023

Dec 6th Webinar – Unmasking Safety Signals in an Infodemic

Please find a link to published recording and presentations of the ‘Unmasking safety signals in an infodemic’ webinar held on...
Read More
Posted on January 6, 2022August 3, 2023

ACIP Meeting Report – Jan 5th 2022

Following the FDA update on the Emergency Use Authorization (EUA) Fact Sheet for Pfizer-BioNTech COVID-19 vaccine on January 3rd 2...
Read More
Posted on August 31, 2021August 3, 2023

Guidance for CEPI Developers

This SPEAC deliverable summarizes Brighton Collaboration guidance on the collection, interpretation analysis and presentation of s...
Read More
Posted on August 31, 2021August 3, 2023

Preliminary guidance on safety data collection for COVID-19 vaccine safety

This deliverable provides guidance on the collection of safety data for COVID-19 vaccine candidates. This includes a brief discuss...
Read More
Posted on June 18, 2021August 3, 2023

Draft List of Core COVID-9 AESIs for Safety Monitoring in LMICs

As global distribution of COVID-19 vaccine expands, the Brighton Collaboration has identified a subset of adverse events of specia...
Read More
Posted on November 6, 2020August 3, 2023

Addendum to Priority List of Adverse Events of Special Interest: COVID-19

The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task For...
Read More
Posted on October 5, 2020August 3, 2023

Repositories of Publications and Safety Profiles from COVID-19 Vaccine Clinical Trials

To find updated repositories of publications and safety profiles from COVID-19 vaccine clinical trials, please visit one or both o...
Read More
Posted on June 10, 2020August 4, 2023

Priority List of Adverse Events of Special Interest: COVID-19

The Coalition for Epidemic Preparedness Innovations (CEPI) has contracted with the Brighton Collaboration, through the Task For...
Read More
Posted on June 4, 2020August 9, 2023

Consensus Summary Report for CEPI/BC March 12-13 2020 Meeting: Assessment of Risk of Disease Enhancement with COVID-19 Vaccines

Since the emergence of a new coronavirus, SARS-CoV-2, in China, there has been an unprecedented need to quickly develop an effecti...
Read More
Previous page 1 2

Recent Posts

  • Safety by Numbers – February 2025February 19, 2025
  • Brighton Collaboration News — Sept 2024September 9, 2024
  • Lessons Learned from Vaccine Safety Surveillance EffortsSeptember 3, 2024
  • Comirnaty COVID-19 mRNA vaccine: standardized template with key considerations for a benefit-risk assessmentAugust 27, 2024
  • Safety by Numbers – August 2024August 14, 2024

Email:
bc-coordinator@taskforce.org

Address:
The Task Force for Global Health,
330 W. Ponce de Leon Ave.
Decatur, GA 30030

  • Case Definitions
  • Safety Templates
  • Covid-19
  • Trusted Sources
Linkedin

© Brighton Collaboration  2023. All rights reserved.

  • Disclaimer and Privacy Policy